150 related articles for article (PubMed ID: 44945)
1. Further characterization of "promptly" and "delayed" human serum-sensitive strains of Serratia marcescens.
Traub WH; Fukushima PI
Zentralbl Bakteriol Orig A; 1979 Dec; 245(4):495-511. PubMed ID: 44945
[TBL] [Abstract][Full Text] [Related]
2. Mammalian serum susceptibility of Serratia marcescens: detection of three human serum susceptibility categories.
Traub WH; Fukushima PI
Zentralbl Bakteriol Orig A; 1979; 245(3):301-11. PubMed ID: 44784
[TBL] [Abstract][Full Text] [Related]
3. Susceptibility of Serratia marcescens to human serum: antagonism of serum bactericidal activity by IgG immunoglobulins of homologous rabbit anti-O sera.
Traub WH
Zentralbl Bakteriol A; 1980 Feb; 246(1):26-49. PubMed ID: 6158811
[TBL] [Abstract][Full Text] [Related]
4. Neutralization of human serum beta-lysin by sodium polyanetholsulfonate and sodium amylosulfate.
Traub WH; Fukushima PI
J Clin Microbiol; 1979 Jul; 10(1):19-26. PubMed ID: 227918
[TBL] [Abstract][Full Text] [Related]
5. Variable neutralization of several nonspecific antibacterial systems in fresh, defibrinated human blood by sodium polyanetholsulfonate and sodium amylosulfate.
Traub WH; Fukushima PI
J Clin Microbiol; 1979 Jul; 10(1):27-31. PubMed ID: 227919
[TBL] [Abstract][Full Text] [Related]
6. Human serum bactericidal activity against Serratia marcescens: failure of human, "natural," specific anti-O IgG antibodies to enhance serum bactericidal activity.
Traub WH
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):84-91. PubMed ID: 7032154
[TBL] [Abstract][Full Text] [Related]
7. Failure of a commercial, intravenously applicable IgG F (ab)2 preparation (Gamma-Venin) to enhance human serum bactericidal activity against Serratia marcescens.
Traub WH
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 249(4):504-11. PubMed ID: 6171949
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of classical and alternative pathway-activated bactericidal activity of human serum by sodium polyanetholsulfonate.
Traub WH; Kleber I
J Clin Microbiol; 1977 Mar; 5(3):278-84. PubMed ID: 192756
[TBL] [Abstract][Full Text] [Related]
9. Studies on the additive effect of polymyxin B and the bactericidal activity of human serum against Serratia marcescens.
Traub WH; Kleber I
Chemotherapy; 1975; 21(3-4):189-204. PubMed ID: 169108
[TBL] [Abstract][Full Text] [Related]
10. Selective activation of classical and alternative pathways of human complement by "promptly serum-sensitive" and "delayed serum-sensitive" strains of Serratia marcescens.
Traub WH; Kleber I
Infect Immun; 1976 May; 13(5):1343-6. PubMed ID: 818023
[TBL] [Abstract][Full Text] [Related]
11. The interaction of Escherichia coli with normal human serum: the kinetics of serum-mediated lipopolysaccharide release and its dissociation from bacterial killing.
Tesh VL; Duncan RL; Morrison DC
J Immunol; 1986 Aug; 137(4):1329-35. PubMed ID: 3525676
[TBL] [Abstract][Full Text] [Related]
12. Host resistance to Serratia marcescens infection: serum bactericidal activity and phagocytosis by normal blood leukocytes.
Simberkoff MS; Ricupero I; Rahal JJ
J Lab Clin Med; 1976 Feb; 87(2):206-17. PubMed ID: 1107450
[TBL] [Abstract][Full Text] [Related]
13. Phagocytosis of Serratia marcescens by leukocytes of fresh defibrinated human blood: failure of "natural" human specific anti-O IgG antibodies to enhance phagocytosis.
Traub WH
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1981; 250(1-2):92-103. PubMed ID: 7032156
[TBL] [Abstract][Full Text] [Related]
14. An outer membrane-disorganizing peptide PMBN sensitizes E. coli strains to serum bactericidal action.
Vaara M; Viljanen P; Vaara T; Mäkelä PH
J Immunol; 1984 May; 132(5):2582-9. PubMed ID: 6325539
[TBL] [Abstract][Full Text] [Related]
15. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
Lagergård T; Frisk A; Purvèn M; Nilsson LA
Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
[TBL] [Abstract][Full Text] [Related]
16. Bactericidal activity of C9-deficient human serum.
Pramoonjago P; Kinoshita T; Hong KS; Takata-Kozono Y; Kozono H; Inagi R; Inoue K
J Immunol; 1992 Feb; 148(3):837-43. PubMed ID: 1730876
[TBL] [Abstract][Full Text] [Related]
17. Interactions of antimicrobial drugs and combined phagocytic/serum bactericidal activity of defibrinated human blood against Serratia marcescens. III. beta-Lactam antibiotics and fosfomycin.
Traub WH
Chemotherapy; 1983; 29(1):48-57. PubMed ID: 6339180
[TBL] [Abstract][Full Text] [Related]
18. Further studies on the susceptibility of Serratia marcescens to the bactericidal activity of human serum. Resistance of isolates against serum transferrin-mediated iron deprivation and chelation of cations by EDTA.
Traub WH
Exp Cell Biol; 1977; 45(3-4):184-206. PubMed ID: 409627
[No Abstract] [Full Text] [Related]
19. Assembly of the membrane attack complex promotes decay of the alternative pathway C3 convertase on Neisseria gonorrhoeae.
Densen P; McRill CM; Ross SC
J Immunol; 1988 Dec; 141(11):3902-9. PubMed ID: 3141507
[TBL] [Abstract][Full Text] [Related]
20. Opsonization requirements of Serratia marcescens.
Traub WH
Zentralbl Bakteriol Mikrobiol Hyg A Med Mikrobiol Infekt Parasitol; 1982 Nov; 253(2):204-24. PubMed ID: 6187137
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
